Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China. The specific amount of the round is yet to be disclosed. Founded in 2015, the company is a biotechnology developer which focuses on cancer diagnosis through gene detection and immunotherapy treatment, one of the […]

IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series B Round appeared first on China Money Network.